KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Assets (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Assets over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly Return on Assets fell 7.0% to 0.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02% through Dec 2025, down 7.0% year-over-year, with the annual reading at 0.03% for FY2025, 8.0% down from the prior year.
  • Return on Assets was 0.02% for Q4 2025 at Jazz Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.08% in Q1 2021 and troughed at 0.04% in Q1 2022.
  • The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.01%.
  • Biggest five-year swings in Return on Assets: dropped -11bps in 2022 and later grew 6bps in 2023.
  • Tracing JAZZ's Return on Assets over 5 years: stood at 0.03% in 2021, then rose by 24bps to 0.02% in 2022, then surged by 283bps to 0.04% in 2023, then grew by 25bps to 0.05% in 2024, then plummeted by -149bps to 0.02% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.02%, 0.02%, and 0.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.